Bonneick Sonja, Boentert Matthias, Berger Philipp, Atanasoski Suzana, Mantei Ned, Wessig Carsten, Toyka Klaus V, Young Peter, Suter Ueli
Institute of Cell Biology, Department of Biology, Swiss Federal Institute of Technology, Zurich, Switzerland.
Hum Mol Genet. 2005 Dec 1;14(23):3685-95. doi: 10.1093/hmg/ddi400. Epub 2005 Oct 25.
Charcot-Marie-Tooth disease (CMT) comprises a family of clinically and genetically very heterogeneous hereditary peripheral neuropathies and is one of the most common inherited neurological disorders. We have generated a mouse model for CMT type 4B1 using embryonic stem cell technology. To this end, we introduced a stop codon into the Mtmr2 locus within exon 9, at the position encoding amino acid 276 of the MTMR2 protein (E276X). Concomitantly, we have deleted the chromosomal region immediately downstream of the stop codon up to within exon 13. The resulting allele closely mimics the mutation found in a Saudi Arabian CMT4B1 patient. Animals homozygous for the mutation showed various degrees of complex myelin infoldings and outfoldings exclusively in peripheral nerves, in agreement with CMT4B1 genetics and pathology. Mainly, paranodal regions of the myelin sheath were affected, with a high degree of quantitative and qualitative variability between individuals. This pathology was progressive with age, and axonal damage was occasionally observed. Distal nerve regions were more affected than proximal parts, in line with the distribution in CMT. However, we found no significant electrophysiological changes, even in aged (16-month-old) mice, suggesting that myelin infoldings and outfoldings per se are not invariably associated with detectable electrophysiological abnormalities. Our animal model provides a basis for future detailed molecular and cellular studies on the underlying disease mechanisms in CMT4B1. Such an analysis will reveal how the disease develops, in particular, the enigmatic myelin infoldings and outfoldings as well as axonal damage, and provide mechanistic insights that may aid in the development of potential therapeutic approaches.
夏科-马里-图斯病(CMT)是一类临床和遗传上具有高度异质性的遗传性周围神经病,是最常见的遗传性神经疾病之一。我们利用胚胎干细胞技术构建了4B1型CMT的小鼠模型。为此,我们在MTMR2蛋白第276位氨基酸(E276X)编码位置的第9外显子内的Mtmr2基因座中引入了一个终止密码子。同时,我们删除了终止密码子下游直至第13外显子内的染色体区域。产生的等位基因紧密模拟了一名沙特阿拉伯CMT4B1患者中发现的突变。该突变的纯合子动物仅在周围神经中表现出不同程度的复杂髓鞘内褶和外褶,这与CMT4B1的遗传学和病理学一致。主要是髓鞘的结旁区域受到影响,个体之间在数量和质量上存在高度变异性。这种病理学变化随年龄进展,偶尔观察到轴突损伤。远端神经区域比近端部分受影响更严重,这与CMT中的分布情况一致。然而,即使在老年(16个月大)小鼠中,我们也未发现明显的电生理变化,这表明髓鞘内褶和外褶本身并不总是与可检测到的电生理异常相关。我们的动物模型为未来对CMT4B1潜在疾病机制进行详细的分子和细胞研究提供了基础。这样的分析将揭示疾病的发展过程,特别是神秘的髓鞘内褶和外褶以及轴突损伤,并提供可能有助于开发潜在治疗方法的机制性见解。